publication venue for
- Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.. -. 2026
- RNAi therapeutics targeting Japanese encephalitis virus: Gene targets, delivery platforms, and translational barriers.. -. 2025
- Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons.. 405:269-79. 2010